Tauvid Injection, Solution
NDC Package 0002-1220-48

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Tauvid (flortaucipir f-18) injection is tAUVID is indicated for use with positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD). This formulation utilizes a injection, solution delivery system. Marketed by Eli Lilly And Company, this product is identified by NDC 0002-1220 and is authorized under FDA application NDA212123.

Identification & Billing

NDC Package Code
0002-1220-48
Package Description
1 VIAL, MULTI-DOSE in 1 CAN / 100 mL in 1 VIAL, MULTI-DOSE
Product Code
0002-1220
11-Digit Billing Format
00002122048

Clinical Specifications

Proprietary Name
Tauvid
Non-Proprietary Name
Flortaucipir F-18
Substance Name
Flortaucipir F-18
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
FLORTAUCIPIR F-18 100 mCi/mL
Usage Information
TAUVID is indicated for use with positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD).

Regulatory & Marketing

Labeler Name
Eli Lilly And Company
Product Type
Human Prescription Drug
FDA Application #
NDA212123
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-01-2022
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0002-1220). Click a package code to view its specific billing and regulatory data.

0002-1220-50
1 VIAL, MULTI-DOSE in 1 CAN / 50 mL in 1 VIAL, MULTI-DOSE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0002-1220-48 identifies a specific commercial package of 1 vial, multi-dose in 1 can / 100 ml in 1 vial, multi-dose of Tauvid, a human prescription drug labeled by Eli Lilly And Company. This injection, solution is formulated for intravenous use and contains flortaucipir f-18 as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Eli Lilly And Company on July 01, 2022. The current certification is valid through December 31, 2027.

How is this Eli Lilly And Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00002122048. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0002-1220-48
11-Digit CMS (5-4-2)
00002-1220-48

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.